Is the NHS wasting billions on unproven treatments while rejecting cheap, effective alternatives?

The NHS regularly denies funding for drugs deemed cost-ineffective by NICE, yet invests in expensive interventions with modest evidence. As NHS budgets shrink and waiting lists grow, should we rethink how we evaluate what actually works?

Anoniem stemmen is mogelijk. Registreer voor een profiel en score.